Yanuki
Health / Celebrity Health
Boxing legend Mike Tyson is sharing his personal journey with obesity and his decision to star in a Super Bowl ad focused on ultra-processed foods. He discusses his partnership with the MAHA Center and their mission to promote healthy eatin...
Health / Weight Loss
Oprah Winfrey has openly discussed her decades-long battle with weight, and a recent epiphany has shifted her perspective. She now views obesity as a treatable disease, not a personal failing, which has influenced her approach to weight man...
Health / Nutrition
Structure Therapeutics has announced positive topline data from its ACCESS program for aleniglipron, a once-daily oral small molecule GLP-1 receptor agonist. The studies show promising results in weight loss for individuals with obesity or...
Health / Weight Loss
Wave Life Sciences (Nasdaq: WVE) has announced positive interim data from its Phase 1 INLIGHT trial of WVE-007 (INHBE), an investigational RNA medicine for treating obesity. The single-dose study demonstrated significant improvements in bod...
Health / Obesity
The landscape of obesity treatment is evolving rapidly with the emergence of new pill-based medications and innovative alternatives to traditional injectables. This article explores the latest advancements in obesity pills and alternative t...
Health and Science / Policy
The Trump administration has announced landmark deals with Eli Lilly and Novo Nordisk to significantly reduce the prices of some obesity drugs, aiming to expand access to these costly treatments. The agreements will affect Medicare and Medi...
Health / Weight Loss
Pfizer's $4.9 billion investment in Metsera is showing early promise. A Phase IIb trial of their obesity drug, MET-097i, has demonstrated a significant 14.1% weight loss in patients. This development positions Pfizer to be a strong contende...
Finance / Pharma
Pfizer (PFE) is strategically re-entering the competitive GLP-1 market, targeting the rapidly expanding obesity drug sector. With the acquisition of Metsera for $4.9 billion, Pfizer aims to secure a significant position in this lucrative ma...
Health / Weight Loss
The once-promising obesity drug market faces a turning point as investor enthusiasm cools amidst concerns over lackluster results, potential copycat drugs, and pricing pressures. Pharmaceutical giants Novo Nordisk and Eli Lilly are now unde...
Health / Health Equity
This health news roundup for July 14, 2025, covers critical issues in health equity, including the disproportionate rise in obesity among minority youth, legal challenges to COVID-19 vaccine rollbacks, disparities in treatment access, and g...
Business / Pharmaceuticals
Eli Lilly (LLY) is witnessing robust demand for its diabetes and weight-loss drug, Mounjaro, in India, driven by increasing rates of obesity and diabetes. The company is focused on meeting this rising demand, positioning Mounjaro as a key p...
Entertainment / Celebrity News
Queen Latifah is making headlines for her upcoming biopic, her performance at Coachella, and her continued advocacy for obesity awareness. Additionally, her influence on queer representation in film is being celebrated through the lens of t...
Healthcare / Pharmaceuticals
Novo Nordisk A/S (NVO), the Denmark-based global healthcare giant, is currently a focal point in the pharmaceutical sector. Fueled by the success of its popular diabetes and obesity treatments like Ozempic and Wegovy, the company's strong f...
